SCHEMBL4422198

SCHEMBL4422198

O=[N+]([O-])C1=CCCC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937547 0.78
SCHEMBL18568339 0.73 ALDH1A1 (0.31)
SCHEMBL22791822 0.67
SCHEMBL1846174 0.65
SCHEMBL349091 0.65
SCHEMBL7701653 0.65 GSK3A (0.32)
SCHEMBL18007273 0.65
SCHEMBL11820953 0.65
SCHEMBL14870927 0.64 FBP1 (0.38)
SCHEMBL2227308 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108993555-A A kind of preparation method of tardive dyskinesia rehabilitation pharmaceutical intermediate 泰山医学院 2018-12-14 CN claimed
CN-106905335-A Quinazo heterocycle compound and its preparation method and application 北京工业大学 2017-06-30 CN claimed
WO-2025226831-A1 PURINE COVALENT BASED CDK12 INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2025-10-30 WO disclosed
CN-111344297-B Cyclic dinucleotides as anticancer agents 百时美施贵宝公司 2023-10-20 CN disclosed
CN-114787136-A Substituted benzimidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed
CN-109422737-A Imidazolone androgen receptor antagonists, preparation method and use 上海时莱生物技术有限公司 2019-03-05 CN disclosed
CN-108993555-A A kind of preparation method of tardive dyskinesia rehabilitation pharmaceutical intermediate 泰山医学院 2018-12-14 CN disclosed
CN-108993555-A A kind of preparation method of tardive dyskinesia rehabilitation pharmaceutical intermediate 泰山医学院 2018-12-14 CN disclosed
CN-107141309-A Heteroaryl compound and its application method 桑诺维恩药品公司 2017-09-08 CN disclosed
CN-106905335-A Quinazo heterocycle compound and its preparation method and application 北京工业大学 2017-06-30 CN disclosed
WO-2017106426-A1 FE NANOPARTICLES WITH PPM CONTENTS OF PD, CU AND/OR NI, REACTIONS IN WATER CATALYZED BY THEM THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-06-22 WO disclosed
WO-2008140197-A1 NOVEL CARBAMOYLOXY ARYL ALKAN ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUND AND METHOD FOR TREATING PAIN, ANXIETY AND DEPRESSION BY ADMINISTERING THE COMPOUND SK HOLDINGS CO., LTD. (KR) 2008-11-20 WO disclosed
CN-101243043-A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field GIULIANI INT LTD (IE) 2008-08-13 CN disclosed
CN-100341873-C Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2007-10-10 CN disclosed
CN-1768059-A Pyrido 2,3-d pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2006-05-03 CN disclosed
CN-1711265-A Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2005-12-21 CN disclosed
EP-1560831-A1 NOVEL AMINO-SUBSTITUTED DIHYDROPYRIMIDO [4,5-D] PYRIMIDIN ONE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041823-A1 NOVEL AMINO-SUBSTITUTED DIHYDROPYRIMIDO[4,5-D]PYRIMIDINONE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed
US-5610303-A MONOAMIDE OXIDASE INHIBITORS UBE INDUSTRIES, LTD. (JP) 1997-03-11 US disclosed
EP-0059884-B1 BENZOFURANE DERIVATIVES, THEIR PREPARATION AND USE SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-22 EP disclosed